BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16370170)

  • 21. Laparoscopic extended pelvic lymph node dissection for high-risk prostate cancer.
    Wyler SF; Sulser T; Seifert HH; Ruszat R; Forster TH; Gasser TC; Bachmann A
    Urology; 2006 Oct; 68(4):883-7. PubMed ID: 17070376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic.
    Weingärtner K; Ramaswamy A; Bittinger A; Gerharz EW; Vöge D; Riedmiller H
    J Urol; 1996 Dec; 156(6):1969-71. PubMed ID: 8911367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of pelvic lymphadenectomy in the management of prostate and bladder cancer.
    Woods ME; Ouwenga M; Quek ML
    ScientificWorldJournal; 2007 Mar; 7():789-99. PubMed ID: 17619762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1%.
    Touijer K; Rabbani F; Otero JR; Secin FP; Eastham JA; Scardino PT; Guillonneau B
    J Urol; 2007 Jul; 178(1):120-4. PubMed ID: 17499306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of lymphadenectomy in prostate cancer.
    Burkhard FC; Schumacher M; Studer UE
    Nat Clin Pract Urol; 2005 Jul; 2(7):336-42. PubMed ID: 16474786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of serial sections, immunohistochemistry, and extension of pelvic lymph node dissection on the lymph node status in clinically localized prostate cancer.
    Wawroschek F; Wagner T; Hamm M; Weckermann D; Vogt H; Märkl B; Gordijn R; Harzmann R
    Eur Urol; 2003 Feb; 43(2):132-6; discussion 137. PubMed ID: 12565770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer.
    Briganti A; Capitanio U; Chun FK; Gallina A; Suardi N; Salonia A; Da Pozzo LF; Colombo R; Di Girolamo V; Bertini R; Guazzoni G; Karakiewicz PI; Montorsi F; Rigatti P
    Eur Urol; 2008 Oct; 54(4):794-802. PubMed ID: 18514383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgeon-led prostate cancer lymph node staging: pathological outcomes stratified by robot-assisted dissection templates and patient selection.
    Altok M; Babaian K; Achim MF; Achim GC; Troncoso P; Matin SF; Chapin BF; Davis JW
    BJU Int; 2018 Jul; 122(1):66-75. PubMed ID: 29446205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laparoscopic pelvic lymph node dissection for prostate cancer: comparison of the extended and modified techniques.
    Stone NN; Stock RG; Unger P
    J Urol; 1997 Nov; 158(5):1891-4. PubMed ID: 9334624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extended pelvic lymphadenectomy in patients with clinically localised prostate cancer: A prospective observational study.
    Ramos JG; Caicedo JI; Cataño JG; Villarraga LG; Trujillo CG; Robledo D; Plata M
    Actas Urol Esp; 2016 Sep; 40(7):446-52. PubMed ID: 26995770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of pelvic lymphadenectomy for prostate cancer--therapeutic?
    Wagner M; Sokoloff M; Daneshmand S
    J Urol; 2008 Feb; 179(2):408-13. PubMed ID: 18076938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should we reconsider the indications for ileo-obturator node dissection with localized prostate cancer?
    Sullivan LD; Rabbani F
    Br J Urol; 1995 Jan; 75(1):33-7. PubMed ID: 7531590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional lymph node staging in prostate cancer: prognostic and therapeutic implications.
    Burkhard FC; Studer UE
    Surg Oncol; 2009 Sep; 18(3):213-8. PubMed ID: 19269808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of preoperative serum prostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer.
    Narayan P; Fournier G; Gajendran V; Leidich R; Lo R; Wolf JS; Jacob G; Nicolaisen G; Palmer K; Freiha F
    Urology; 1994 Oct; 44(4):519-24. PubMed ID: 7524237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection.
    Häcker A; Jeschke S; Leeb K; Prammer K; Ziegerhofer J; Sega W; Langsteger W; Janetschek G
    J Urol; 2006 Nov; 176(5):2014-8; discussion 2018-9. PubMed ID: 17070241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended pelvic lymphadenectomy for prostate cancer: should the Cloquet's nodes dissection be considered only an option?
    Cacciamani GE; Porcaro AB; Sebben M; Tafuri A; Rizzetto R; De Luyk N; Ciocchetta E; Processali T; Pirozzi M; Amigoni N; Corsi P; Brunelli M; De Marco V; Artibani W
    Minerva Urol Nefrol; 2019 Apr; 71(2):136-145. PubMed ID: 30767495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.
    Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Fossati N; Stabile A; Beauval JB; Malavaud B; Roumiguié M; Robesti D; Dell'Oglio P; Moschini M; Zamboni S; Rakauskas A; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
    Eur Urol; 2019 Mar; 75(3):506-514. PubMed ID: 30342844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The role of pelvic lymphadenectomy in clinically localised prostate cancer].
    Schumacher M; Burkhard FC; Studer UE
    Urologe A; 2005 Jun; 44(6):645-51. PubMed ID: 15871005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of nodal metastases at laparoscopic pelvic lymphadenectomy using PSA, Gleason score, and clinical stage in men with localized prostate cancer.
    Hoenig DM; Chi S; Porter C; Tackett L; Smith DS; Cohen SI; Stein BS
    J Endourol; 1997 Aug; 11(4):263-5. PubMed ID: 9376845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overtreatment of prostate cancer may be prevented by extended pelvic lymphadenectomy.
    Azawi NH; Stenfeldt K; Christensen T
    Dan Med J; 2013 Sep; 60(9):A4709. PubMed ID: 24001469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.